Results 161 to 170 of about 170,164 (388)

Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Aims To assess whether combining nicotine replacement therapy (NRT) with varenicline improves long‐term smoking cessation rates compared with varenicline or NRT alone. Method Systematic review and meta‐analysis of randomized controlled trials (RCTs) or quasi‐RCTs, conducted according to PRISMA guidelines.
Xinmei Zhou, Zhenxiao Huang, Qingqing Song, Xin Xia, Anqi Cheng, Zhao Liu, Min Wang, Tingfen Ji, Ailifeire Aihemaiti, Ying Xie, Yi Liu, Yuxin Shi, Shunyi Shi, Yingman Gao, Hang Liu, Jiahui He, Liang Zhao, Dan Xiao, Chen Wang   +18 more
wiley   +1 more source

Correction: G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence—study protocol of a randomized, double-blind, placebo-controlled crossover study [PDF]

, 2022
Lea Wetzel, Madeleine Pourbaix, Alisa Riegler, Anna-Maria Pfeifer, Iris Reinhard, Sabine Hofmann, Sabine Vollstädt‐Klein, Falk Kiefer, Wolfgang H. Sommer, Jan Malte Bumb, Patrick Bach, Anne Koopmann   +11 more
openalex   +1 more source

Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Smoking is the leading preventable cause of premature death in China, yet less than 10% of smokers seeking to quit receive treatment. This study aimed to test the efficacy of a cognitive behavioral therapy (CBT)‐based smoking cessation intervention (‘Smokefree Life’) via a smartphone app in China. Design A digital, parallel,
Jinsong Tang, Xiaocong Liu, Shanshan Chen, Yunkai Sun, Minzhe Zhu, Zitang Zhou, Yueheng Liu, Jie Yang, Wei Chen, Yanhui Liao   +9 more
wiley   +1 more source

Gender Differences in the Relationship between Depressive Symptoms and Cravings in Alcoholism

, 2010
Nelli Boykoff, Terry D. Schneekloth, Daniel K. Hall‐Flavin, Larissa L. Loukianova, Victor M. Karpyak, Susanna R. Stevens, Joanna M. Biernacka, David A. Mrazek, Mark A. Frye   +8 more
openalex   +1 more source

Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol‐free and low‐alcohol products in higher risk groups

Addiction, EarlyView.
Abstract Alcohol‐free and low‐alcohol drinks (no/lo drinks) are now widely available and popular with consumers in high‐income countries; however, it is unclear whether clinicians and others working to prevent or treat severe alcohol‐related health problems should take a zero‐tolerance approach to these alcohol‐like products or encourage patients to ...
John Holmes, Christopher K. Oldroyd, Colin Drummond, Matt Field, Inge Kersbergen, Michael E. D. Allison   +5 more
wiley   +1 more source

Alcohol approach–avoidance task behavior and brain potentials differentially predict ecologically assessed alcohol craving and consumption in early emerging adulthood

Addiction, EarlyView.
Abstract Aims The current study measured the extent to which different neurobehavioral indices of incentive‐motivational salience attribution to alcohol cues predict alcohol craving and consumption in the natural environment. Design, setting, and participants Laboratory study at a university in Missouri, USA, followed by a smartphone‐based 21‐day ...
Roberto U. Cofresí, Sandie Keerstock, Casey B. Kohen, Thomas M. Piasecki, Bruce D. Bartholow   +4 more
wiley   +1 more source

Incubation of Methamphetamine and Palatable Food Craving after Punishment-Induced Abstinence [PDF]

, 2014
Irina N. Krasnova, Nathan J. Marchant, Bruce Ladenheim, Michael T. McCoy, Leigh V. Panlilio, Jennifer M. Bossert, Yavin Shaham, Jean Lud Cadet   +7 more
openalex   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Connectome-based prediction of craving in gambling disorder and cocaine use disorder [PDF]

, 2023
Stephanie Antons, Sarah W. Yip, Cheryl Lacadie, Javid Dadashkarimi, Dustin Scheinost, Matthias Brand, Marc N. Potenza   +6 more
openalex   +1 more source

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Addiction, EarlyView.
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley   +1 more source